LC

Lynda Cheng

Starpharma Holdings Limited | Non-Executive Director
Ms Cheng has a background in corporate finance and operational management with more than 30 years of experience including 20 years at Visy Industries/Pratt Holdings and 10 years in investment banking. She has commercial and international corporate expertise including experience in manufacturing, supply chain management, finance, infrastructure, and education as well as market entry, growth and technology. Ms Cheng is currently Director of Corporate Development and Mergers & Acquisitions at Visy Industries/Pratt Holdings and has held various other senior executive team roles in the group including CFO. Ms Chengs earlier roles include as a lawyer at Blake Dawson, before moving into investment banking with J.P. Morgan in its Melbourne, Sydney, San Francisco and New York offices. Ms Cheng has served as a non-executive director of Export Finance Australia, a member of the Australian Governments International Development Policy Expert Panel, the Deputy Chair and Chair of the Finance, Audit and Risk committee of South East Water and a non-executive member of the board at JRJJ Capital, the parent company of Merricks Capital, in an observer/advisory capacity. She is a Member of Audit and Risk Committee.

Company and Role

Company
Title
Tenure
Since
SPL
Starpharma Holdings Limited
  • Non-Executive Director
5yrs, 2mthAug 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
SPL
Starpharma Holdings Limited
11/08/260193,296N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
SPL
Starpharma Holdings Limited
11/08/26
Issued
22,741$0.570$12,962Rights issue
SPL
Starpharma Holdings Limited
25/06/24
Buy
110,555$0.090$9,950On-market trade